Shah S - Search Results

1

Instigation of the epoch of nanovaccines in cancer immunotherapy.

Shah S, Famta P, Tiwari V, Kotha AK, Kashikar R, Chougule MB, Chung YH, Steinmetz NF, Uddin M, Singh SB, Srivastava S. Shah S, et al. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 May-Jun;15(3):e1870. doi: 10.1002/wnan.1870. Epub 2022 Nov 21. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023. PMID: 36410742 Free PMC article. Review.

2

Bridging the gap: academia, industry and FDA convergence for nanomaterials.

Shah S, Nene S, Rangaraj N, Raghuvanshi RS, Singh SB, Srivastava S. Shah S, et al. Drug Dev Ind Pharm. 2020 Nov;46(11):1735-1746. doi: 10.1080/03639045.2020.1821055. Epub 2020 Sep 14. Drug Dev Ind Pharm. 2020. PMID: 32901536 Review.

3

Nanomedicine based approaches for combating viral infections.

Shah S, Chougule MB, Kotha AK, Kashikar R, Godugu C, Raghuvanshi RS, Singh SB, Srivastava S. Shah S, et al. J Control Release. 2021 Oct 10;338:80-104. doi: 10.1016/j.jconrel.2021.08.011. Epub 2021 Aug 8. J Control Release. 2021. PMID: 34375690 Free PMC article. Review.

4

Enigmatic role of exosomes in breast cancer progression and therapy.

Famta P, Shah S, Khatri DK, Guru SK, Singh SB, Srivastava S. Famta P, et al. Among authors: shah s. Life Sci. 2022 Jan 15;289:120210. doi: 10.1016/j.lfs.2021.120210. Epub 2021 Dec 5. Life Sci. 2022. PMID: 34875250 Review.

5

Exploring new Horizons in overcoming P-glycoprotein-mediated multidrug-resistant breast cancer via nanoscale drug delivery platforms.

Famta P, Shah S, Chatterjee E, Singh H, Dey B, Guru SK, Singh SB, Srivastava S. Famta P, et al. Among authors: shah s. Curr Res Pharmacol Drug Discov. 2021 Sep 6;2:100054. doi: 10.1016/j.crphar.2021.100054. eCollection 2021. Curr Res Pharmacol Drug Discov. 2021. PMID: 34909680 Free PMC article. Review.

6

Advances in nanoparticle mediated targeting of RNA binding protein for cancer.

Kashikar R, Kotha AK, Shah S, Famta P, Singh SB, Srivastava S, Chougule MB. Kashikar R, et al. Among authors: shah s. Adv Drug Deliv Rev. 2022 Jun;185:114257. doi: 10.1016/j.addr.2022.114257. Epub 2022 Apr 2. Adv Drug Deliv Rev. 2022. PMID: 35381306 Review.

7

Nanotechnological Advances for Nose to Brain Delivery of Therapeutics to Improve the Parkinson Therapy.

Khatri DK, Preeti K, Tonape S, Bhattacharjee S, Patel M, Shah S, Singh PK, Srivastava S, Gugulothu D, Vora L, Singh SB. Khatri DK, et al. Among authors: shah s. Curr Neuropharmacol. 2023;21(3):493-516. doi: 10.2174/1570159X20666220507022701. Curr Neuropharmacol. 2023. PMID: 35524671 Free PMC article. Review.

8

Biomimetic nanotherapeutics: Employing nanoghosts to fight melanoma.

Bagasariya D, Charankumar K, Shah S, Famta P, Khatri DK, Singh Raghuvanshi R, Bala Singh S, Srivastava S. Bagasariya D, et al. Among authors: shah s. Eur J Pharm Biopharm. 2022 Aug;177:157-174. doi: 10.1016/j.ejpb.2022.06.014. Epub 2022 Jul 3. Eur J Pharm Biopharm. 2022. PMID: 35787429 Review.

9

Nanotechnology based drug delivery systems: Does shape really matter?

Shah S, Famta P, Bagasariya D, Charankumar K, Amulya E, Kumar Khatri D, Singh Raghuvanshi R, Bala Singh S, Srivastava S. Shah S, et al. Int J Pharm. 2022 Sep 25;625:122101. doi: 10.1016/j.ijpharm.2022.122101. Epub 2022 Aug 9. Int J Pharm. 2022. PMID: 35961415 Review.

10

Advancements in redox-sensitive micelles as nanotheranostics: A new horizon in cancer management.

Sikder A, Vambhurkar G, Amulya E, Bagasariya D, Famta P, Shah S, Khatri DK, Singh SB, Sinha VR, Srivastava S. Sikder A, et al. Among authors: shah s. J Control Release. 2022 Sep;349:1009-1030. doi: 10.1016/j.jconrel.2022.08.008. Epub 2022 Aug 12. J Control Release. 2022. PMID: 35961470 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15,458 results

Search Page